๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Methyl CCNU and adriamycin for patients with metastatic sarcomas a southwest oncology group study

โœ Scribed by Saul E. Rivkin; Jeffrey A. Gottlieb; Tate Thigpen; Nazli Gad El Mawla; John Saiki; Dennis O. Dixon


Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
401 KB
Volume
46
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Adriamycin in combination for the treatm
โœ Dr. B. Tranum; B. Hoogstraten; A. Kennedy; C. B. Vaughn; B. Samal; T. Thigpen; S ๐Ÿ“‚ Article ๐Ÿ“… 1978 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 431 KB ๐Ÿ‘ 2 views

Patients with advanced breast cancer who had not previously received chemotherapy were treated on a three-arm prospective study: adriamycin day 1 plus 5-FU on day 1 and 8 (AF), adriamycin day 1 , plus 5-FU day 1 and 8 , and cyclophosphamide day 1 (AFC), and adriamycin day 1 plus 5-FU day 1 and 8 , c

Treatment of unresectable or metastatic
โœ Pratt, Charles B.; Maurer, Harold M.; Gieser, Peter; Salzberg, Arnold; Rao, Bhas ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 139 KB ๐Ÿ‘ 1 views

Background. The objectives of this study were to compare vincristine/actinomycin D/cyclophosphamide/adriamycin (VACA) with VACA plus imidazole carboxamide (DTIC) (VACAD) therapy in regards to complete/partial response and event free survival rates in children and adolescents with metastatic non-rhab